S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
OTCMKTS:VTXPF

Victrex (VTXPF) Stock Price, News & Analysis

$16.36
+0.38 (+2.38%)
(As of 03/27/2024 ET)
Today's Range
$16.36
$16.36
50-Day Range
$15.66
$19.71
52-Week Range
$15.66
$20.03
Volume
117 shs
Average Volume
489 shs
Market Capitalization
$1.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VTXPF stock logo

About Victrex Stock (OTCMKTS:VTXPF)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities. It serves automotive, aerospace, energy and industrial, electronics, and medical markets. Victrex plc was incorporated in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.

VTXPF Stock Price History

VTXPF Stock News Headlines

Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Victrex (VCTX)
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Victrex's (LON:VCT) Dividend Will Be £0.1342
Victrex 1Q Revenue Rose on Better-Than-Expected Prices
Victrex plc (VTXPF) Q4 2022 Earnings Call Transcript
Victrex FY 2022 Pretax Profit Fell on Increased Costs
Do analysts think that Victrex is a buy, hold or sell?
Are analysts backing shares in Victrex?
See More Headlines
Receive VTXPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Victrex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:VTXPF
Previous Symbol
NASDAQ:VTXPF
CIK
N/A
Employees
1,109
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$376.57 million
Cash Flow
$1.24 per share
Book Value
$7.07 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.42 billion
Optionable
Not Optionable
Beta
0.90
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jakob O. Sigurdsson BA (Age 60)
    MBA, CEO & Executive Director
    Comp: $1.02M
  • Mr. Ian Clifford Melling F.C.A. (Age 46)
    CFO & Executive Director
    Comp: $560.73k
  • Mr. Jeff Versterre
    Chief Operating Officer
  • Mr. Andrew Hanson
    Director of Investor Relations & Corporate Communications
  • Ms. Jane Brisley
    General Counsel & Company Secretary
  • Ms. Jilly Atherton
    Group Human Resource Director
  • Dr. John Devine Bsc Ph.D.
    Managing Director for Medical

VTXPF Stock Analysis - Frequently Asked Questions

Should I buy or sell Victrex stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Victrex in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" VTXPF shares.
View VTXPF analyst ratings
or view top-rated stocks.

How have VTXPF shares performed in 2024?

Victrex's stock was trading at $19.51 at the beginning of 2024. Since then, VTXPF stock has decreased by 16.1% and is now trading at $16.36.
View the best growth stocks for 2024 here
.

How do I buy shares of Victrex?

Shares of VTXPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VTXPF) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners